| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.54B | 9.33B | 21.82B | 8.29B | 4.04B | 3.28B |
| Gross Profit | 13.25B | 4.58B | 21.82B | 8.29B | 4.04B | 3.28B |
| EBITDA | 19.43B | 9.91B | 26.45B | 11.19B | 3.19B | 1.95B |
| Net Income | 13.07B | 6.08B | 18.11B | 7.57B | 2.02B | 1.17B |
Balance Sheet | ||||||
| Total Assets | 96.34B | 83.30B | 79.05B | 56.30B | 34.92B | 32.12B |
| Cash, Cash Equivalents and Short-Term Investments | 24.83B | 19.28B | 22.14B | 18.94B | 2.32B | 2.33B |
| Total Debt | 9.36B | 4.02B | 3.41B | 5.22B | 7.01B | 7.42B |
| Total Liabilities | 27.83B | 20.87B | 21.42B | 16.43B | 15.51B | 14.76B |
| Stockholders Equity | 68.48B | 62.42B | 57.62B | 39.86B | 19.41B | 17.36B |
Cash Flow | ||||||
| Free Cash Flow | 10.32B | 13.52B | 5.81B | 5.62B | 382.37M | -1.74B |
| Operating Cash Flow | 10.36B | 13.60B | 5.82B | 5.63B | 383.05M | -1.72B |
| Investing Cash Flow | -36.00M | -84.00M | -102.00M | -5.00M | -684.00K | -21.64M |
| Financing Cash Flow | 4.93B | -1.39B | -2.50B | 10.99B | -382.11M | 1.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥67.17B | 11.62 | 17.21% | 4.27% | 13.39% | 22.06% | |
72 Outperform | ¥111.37B | 3.99 | ― | 0.87% | -16.89% | -16.47% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥120.31B | 30.49 | 5.11% | 5.07% | -26.93% | -29.39% | |
67 Neutral | ¥174.85B | 10.15 | 7.40% | 5.60% | 15.68% | 49.07% | |
44 Neutral | ¥20.52B | -17.28 | ― | 1.85% | -17.48% | -207.17% | |
43 Neutral | ¥15.34B | -11.91 | ― | ― | 180.01% | 33.62% |